All News

Two KEYNOTE trials were placed on full clinical hold and 1 partial clinical hold.

Abatacept (Orencia) receives approval for third autoimmune condition.

Prembrolizumab (Keytruda) combination observed to have a high mortality rate.

Orencia has already been approved for two other autoimmune conditions.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at the top stories in pharmacy last week.

Research may lead to the development of safer therapies for pregnant women with rheumatoid arthritis.

Researchers at the University of Bristol in the United Kingdom have published a study in European Respiratory Journal that analyzed sugar intake during pregnancy and the relationship to allergies and asthma in children.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The approval greatly expands treatment options for rare inherited blood disorder.

L-glutamine powder (Endari) is the first drug approved to treat sickle cell disease in nearly 20 years.

The results of the University of Michigan National Poll on Healthy Aging show that many Americans older than 50 take two or more prescription medications that take a toll on their finances.

Scientists highlight the potential use of exosomes to detect and treat diseases.

Changing from a biologic to a biosimilar can create insecurity among patients with RA.

Top articles of the week from Specialty Pharmacy Times.

Liraglutide is an injectable prescription drug that may improve glucose in adults with type 2 diabetes.

Use of mHealth grows as healthcare stakeholders invest in technological solutions.

Elevated protein levels may indicate a need for both chemotherapy and surgery for colon cancer.

Patients nearing the end of their lives may wish to stop treatment with statins due to side effects.

Anti-fungal therapy may prove beneficial in patients with Crohn’s disease.

Horse-riding and rhythm-and-music therapy improved stroke recovery perception among patients.

Top news of the day from across the health care landscape.

Prebiotics seen to reduce weight gain among pediatric patients who were overweight or obese.

Top news of the day from across the healthcare landscape.

Many areas of medicine that intersect with law and immunizations are associated with a very specific set of laws across the nation.

Endo International has announced its plan to withdraw Opana ER (oxymorphone hydrochloride extended release) from the market.

The FDA has approved Bristol-Myers Squibb’s abatacept (Orencia) in both intravenous (IV) and subcutaneous (SC) injections forms for the treatment of active Psoriatic Arthritis (PsA) in adults. The approval is the third autoimmune disease indication for Orencia.

FDA officials said that U.S. District Judge William H. Steele has entered a consent decree of permanent injunction against compounder Medistat RX, LLC, prohibiting the company from manufacturing or distributing products until it complies with appropriate regulations.